Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group
Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
12/2013
12/12/2013WO2013182972A1 Benzimidazole-proline derivatives
12/12/2013WO2013182636A1 Synthesis of a viral protease inhibitor
12/12/2013US20130331419 Mineralocorticoid receptor antagonists
12/12/2013US20130331382 Pyridinone and Pyridazinone Derivatives
12/12/2013US20130331380 Dihydroindolone compounds, a process for their preparation and pharmaceutical compositions containing them
12/12/2013US20130331377 Diaminopyrimidine derivatives and processes for the preparation thereof
12/12/2013US20130331370 Certain kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof
12/12/2013US20130331328 Small molecule inhibitors of agbl2
12/12/2013US20130328021 Compound for organic light-emitting device and organic light-emitting device including the same
12/12/2013CA2875966A1 Compounds and compositions for modulating egfr activity
12/12/2013CA2875508A1 Synthesis of antiviral compound
12/11/2013EP2671876A2 Pyrazine derivatives and their use as protein kinase inhbitors
12/11/2013EP2671875A1 1-aryl-3-aminoalkoxy pyrazoles as sigma ligands enhancing analgesic effect of opioids and attenuating the dependency thereof
12/11/2013EP2670736A1 9-[4-(3-chlor-2-fluor-phenylamino)-7-methoxy-quinazolin-6-yloxy]-1,4-diaza-spiro[5.5]undecan-5-one dimaleate, use thereof as a drug, and production thereof
12/11/2013CN1956952B Histamine H3 receptor agents, preparation and therapeutic uses
12/11/2013CN103443094A Pyrazole derivative
12/11/2013CN103443081A Imidazole compound production method, imidazole compound, imidazole-based compound, organic metal complex, material for organic electroluminescent element, organic electroluminescent element, display device, and lighting device
12/11/2013CN103443074A Heterocyclic amine derivatives
12/11/2013CN103442569A Ectoparasiticidal active substance combinations
12/11/2013CN103435606A CDK2 and CSK3beta dual inhibitor and application thereof
12/11/2013CN103435599A Solid-phase preparation method of avanafil
12/11/2013CN103435598A Preparation method of Barasertib
12/11/2013CN103435597A 1,3,5-triazine derivative and application thereof in white organic electroluminescent light emitting diode
12/11/2013CN103435596A Tetrazole substituted anthranilic acid amides as pesticides
12/11/2013CN103435595A Acetylenic heteroaryl compounds
12/11/2013CN103435594A 2-amino-quinazolines PLK1 (Polo-like kinase1) inhibitor and application thereof
12/11/2013CN103435562A 6-substituted benzodiazepine-2,4-diketone compound and application thereof
12/11/2013CN102533252B Organic luminescent material and organic electroluminescent device
12/11/2013CN102333772B Anti-viral compounds
12/11/2013CN101516844B 4-heteroaryl-substituted 1-aminocyclohexane-1- and cyclohexene-1-derivatives having effects on the opiod receptor system
12/10/2013US8604217 Compound, a process for its preparation, a pharmaceutical composition, use of a compound, a method for modulating or regulating serine/threonine kinases and a serine/threonine kinases modulating agent
12/10/2013US8604191 Synthesis and novel salt forms of (R)-5-((E)-2-pyrrolidin-3YLVINYL)pyrimidine
12/10/2013US8604042 Bi-aryl meta-pyrimidine inhibitors of kinases
12/10/2013US8604037 Therapeutic agents useful for treating pain
12/10/2013US8604032 Chemical compounds, compositions and methods for kinase modulation
12/10/2013US8604023 1,4-benzodiazepinone compounds and their use in treating cancer
12/10/2013US8604022 N-[5-[2-(3,5-dimethoxyphenyl)ethyl]-1h-pyrazol-3-yl]-4-(3,4-dimethylpiperazin-1-yl)benzamide and salts thereof
12/10/2013US8604017 Azetidinyl diamides as monoacylglycerol lipase inhibitors
12/10/2013US8603446 Cosmetic composition, compound and cosmetic treatment method
12/10/2013CA2608957C Pyrrolidine derivative or salt thereof
12/10/2013CA2599511C 2-(4-oxo-4h-quinazolin-3-yl) acetamides and their use as vasopressin v3 antagonists
12/05/2013WO2013181135A1 Quinazoline derivatives, compositions, and uses related thereto
12/05/2013WO2013180656A1 ICMT Inhibitors
12/05/2013WO2013180456A1 Novel organic electroluminescent compounds and organic electroluminescent device comprising the same
12/05/2013WO2013180097A1 Organic electroluminescent element
12/05/2013WO2013179034A1 New compounds
12/05/2013WO2013178591A1 Aminoquinazoline and pyridopyrimidine derivatives
12/05/2013WO2013178572A1 Triazolo compounds as pde10 inhibitors
12/05/2013WO2013178075A1 N-aryl unsaturated fused ring tertiary amine compound, preparation method thereof and antitumor application thereof
12/05/2013WO2013178031A1 New forms of telaprevir and preparation methods thereof
12/05/2013WO2013153479A3 Indole and indazole compounds that activate ampk
12/05/2013WO2013132352A3 Covalent functionalization of carbon nanotubes grown on a surface
12/05/2013WO2011038185A3 Methods for preparing pyrimidine derivatives useful as protein kinase inhibitors
12/05/2013US20130324740 Synthesis of antiviral compound
12/05/2013US20130324725 Aminopyrimidines useful as kinase inhibitors
12/05/2013US20130324560 Anthranilic acid diamide derivative with hetero-aromatic and hetero-cyclic substituents
12/05/2013US20130324532 Fak inhibitors
12/05/2013US20130324529 Benzimidazole cannabinoid agonists bearing a substituted heterocyclic group
12/05/2013US20130324524 2,4-pyrimidinediamine compounds and their uses
12/05/2013US20130324521 Implant for treating or preventing an aneurysm
12/05/2013US20130324519 Quinoxaline carboxamide derivatives as protein tyrosine kinase inhibitors
12/05/2013US20130324517 Cyclic pyrimidin-4-carboxamides as ccr2 receptor antagonists for treatment of inflammation, asthma and copd
12/05/2013US20130324496 Solid forms of an antiviral compound
12/05/2013CA2874911A1 New compounds
12/04/2013EP2669272A1 Indole derivative and pharmacologically acceptable salt of same
12/04/2013EP2669270A1 Ring-fused compound
12/04/2013EP2668247A1 Phototherapy devices and methods comprising optionally substituted terphenyl and quaterphenyl compounds
12/04/2013EP2668181A1 Pyrazole compounds as crth2 antagonists
12/04/2013EP2668180A2 Bcl-2/bcl-xl inhibitors and therapeutic methods using the same
12/04/2013EP2668167A1 Amino-substituted 3-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals
12/04/2013CN103429587A New azaspirodecanone compounds as HSL inhibitors
12/04/2013CN103429585A Indazolyl triazole derivatives as irak inhibitors
12/04/2013CN103429582A MST1 kinase inhibitors and method of use thereof
12/04/2013CN103429569A New azaspirodecanone compounds
12/04/2013CN103421005A Acetylene derivative capable of resisting activity of tumor
12/04/2013CN103420991A Pyrrolidine derivative used as hepatitis c inhibitor and application thereof in medicine
12/04/2013CN103420988A Pyridinone and pyridazinone derivatives as inhibitors of poly(adp-ribose)polymerase (parp)
12/04/2013CN103420890A 3-pyrrole carboxylic acid derivatives, and preparing method and application thereof
12/03/2013US8598217 Imidazole derivatives and their use as modulators of cyclin dependent kinases
12/03/2013US8598187 Arylamide pyrimidone compounds
12/03/2013US8598181 Modulators of ATP-binding cassette transporters
12/03/2013US8598180 Tetrahydroindolone derivatives for treatment of neurological conditions
12/03/2013US8598176 Pyridazine compound and use thereof
12/03/2013US8598175 Heteroarylamide pyrimidone derivatives
12/03/2013US8597903 Biotinidase assay
12/03/2013CA2570987C Novel alkynyl derivatives as modulators of metabotropic glutamate receptors
12/03/2013CA2516660C Novel benzimidazole and imidazopyridine derivatives and use thereof as a medicament
11/2013
11/28/2013WO2013176698A1 Carboline and carbazole based imaging agents for detecting neurological dysfunction
11/28/2013WO2013176402A1 Indole compound, compound for organic electric element containing derivative thereof, organic electric element using same, and corresponding electronic device
11/28/2013WO2013176194A1 Organic electroluminescent element, organic electroluminescent lighting device, and organic electroluminescent display device
11/28/2013WO2013175789A1 Material for organic electroluminescent elements, and organic electroluminescent element using same
11/28/2013WO2013175746A1 Organic electroluminescent element
11/28/2013WO2013175388A1 Novel ring-substituted n-pyridinyl amides as kinase inhibitors
11/28/2013WO2013175211A1 Hydantoin derivatives as kv3 inhibitors
11/28/2013WO2013174937A1 Substituted pyrrolidines as factor xia inhibitors for the treatment thromboembolic diseases
11/28/2013WO2013174895A1 Heterocyclyl pyrimidine analogues as tyk2 inhibitors
11/28/2013WO2013174843A1 N-(tetrazol-5-yl)- and n-(triazol-5-yl)arylcarboxylic thioamides and use thereof as herbicides
11/28/2013WO2013174075A1 Iridium complex containing functional group for hole transporting and electroluminescent device thereof
11/28/2013WO2013173905A1 Biocidal compounds and methods for using same
11/28/2013US20130317216 2,4-pyrimidinediamine compounds and their uses
1 ... 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 ... 626